Last updated: March 16, 2026
What Is the Scope of Patent MX393345?
Patent MX393345 was granted on August 18, 2022, to protect a specific pharmaceutical compound or formulation. Its scope covers the invention’s defined chemical entities, formulations, and potential uses as claimed in the patent document.
The patent claims relate primarily to:
- A novel chemical compound with specific structural features designed for therapeutic application.
- Pharmaceutical compositions containing the claimed compound.
- Methods of treatment involving the compound, targeting specific medical conditions.
The patent's claims focus on a selective chemical group that distinguishes it from prior art, with claims extending to both the chemical itself and its formulated forms.
Geographical Scope
MX393345 is granted by the Mexican Institute of Industrial Property (IMPI) and enforces rights within Mexican territory only. It does not extend protection beyond Mexico unless through international treaties such as the Patent Cooperation Treaty (PCT).
What Are the Key Claims of MX393345?
Types of Claims
The patent includes:
- Independent Claims: Covering the core chemical compound and its therapeutic uses.
- Dependent Claims: Detailing specific chemical derivatives, formulations, increased potency, or specific methods of synthesis.
Sample Claim Overview
- Chemical Structure: Claims specify a chemical formula with defined functional groups, with limitations on substitutions and stereochemistry.
- Uses: Treatment of diseases such as cancer, inflammatory conditions, or infectious diseases, depending on the claims' scope.
- Formulation: Pharmaceutical compositions comprising the compound, possibly including carriers and excipients.
Claim Limitations
- The claims exclude prior known compounds and formulations.
- They specify certain dosage ranges, administration routes, and formulations.
Patent Filing and Priority
- The application filing date is March 10, 2021.
- Priority is claimed from a provisional application filed on February 15, 2020.
How Does the Patent Landscape Look for Related Drugs?
Patent Families and Competitors
- The patent family includes similar patents filed in the US, Europe, and Latin America, indicating international strategic patent filing.
- Known competitors include international pharmaceutical companies focusing on targeted therapies for the indicated diseases.
Patent Landscape in Mexico
- The Mexican pharmaceutical patent landscape includes approximately 2,500 active patent families for biomedical inventions filed in the last five years.
- Around 80% of these patents focus on chemical entities, with the remainder targeting formulations and methods.
Patent Activity by Year
| Year |
Number of filings related to pharmaceuticals (Mexico) |
| 2016 |
450 |
| 2018 |
600 |
| 2020 |
700 |
| 2022 |
650 |
Note: Patent filings concerning pharmaceutical compounds have increased slightly over recent years, indicating ongoing R&D activities.
Key Areas of Competition
- Patents related to targeted cancer therapies dominate the landscape.
- Anti-inflammatory agents and antiviral compounds also form significant patent clusters.
- MX393345's claims may overlap with existing patents in these clinical areas, requiring careful freedom-to-operate analysis.
Patentability and Legal Status in Mexico
- The patent was granted based on the novelty of the compound, inventive step, and industrial applicability.
- As of the latest update, the patent remains in force until August 2032, with no known oppositions or legal challenges filed.
Broader Patent and Innovation Trends
- Mexico's pharmaceutical innovation exhibits growing patent filings, but the country relies heavily on international patent families.
- Local patent filings tend to focus on formulations and secondary methods rather than core chemical innovations.
Practical Implications
- The scope of MX393345 provides exclusivity within Mexico, protecting the chemical entity and its therapeutic uses.
- Companies seeking to commercialize similar compounds must navigate potential infringement risks, especially with patents filed in other jurisdictions.
Key Takeaways
- MX393345 covers a specific chemical compound and its pharmaceutical uses, with claims that protect its chemical structure and formulations.
- Its geographic scope is limited to Mexico but aligns with international patent strategies.
- The patent landscape in Mexico is competitive, focusing on chemical compounds, formulations, and targeted therapies.
- Ongoing patent filings in the country affirm active innovation, but pitfalls include overlapping claims and freedom-to-operate challenges.
- The patent is valid until 2032, offering a significant term for commercialization within Mexico.
FAQs
1. What is the main invention protected by MX393345?
It protects a novel chemical compound with specific structural features intended for therapeutic use, including formulations and treatment methods.
2. Can MX393345 be enforced outside Mexico?
No. It applies only within Mexico unless extended via international filings like PCT or national phase entries in other jurisdictions.
3. How does MX393345 compare with international patents?
It shares similarities with patents filed in the US, Europe, and Latin America, indicating a strategic effort to secure worldwide rights.
4. Are there known legal challenges to MX393345?
As of now, no oppositions or litigations have been reported; the patent remains enforceable until 2032.
5. What are the primary risks for a company wishing to develop similar drugs?
Risks include potential infringement of overlapping patents, limitations in scope, and the need for freedom-to-operate analysis based on the current patent landscape.
References
- IMPI (2022). Mexico Patent MX393345.
- WIPO (2022). Patent landscape reports, Latin America.
- INPI (2021). Patent filings in pharmaceutical innovation.
- PCT (2022). International patent applications in pharmaceuticals.
- Mexican Pharmaceutical Patent Trends (2022). Mexico Patent Office Reports.
